ARTIVION, INC. insider trading
CRYNYSE$15.43-0.42 (-2.65%)as of Oct 2, 2026
“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch
Insider Trading vs Stock Price
Insider Trading vs Stock Price data
Showing the 1Y range: Apr 28, 2026 to Oct 2, 2026. Price (-38.2%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.
| Date | Category | Person | Role | Action | Amount | Change in holding |
|---|
Marker size reflects transaction size.
Net dollar flow · Buy / Sell balance
PremiumQ2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flowKey players
AI Activity Analysis
PremiumComing soonAI reads of insider activity will appear here for Premium accounts.
Insider activity
Fromto
| Company | Insider / role | Action | ΔOwn | Avg price | Amount | ||
|---|---|---|---|---|---|---|---|
| Andrew M. GreenSVP, Regulatory and Quality | Open market sell$287K | -22.2% | $24.97 | $287K | Sep 10, 2026 | Sep 11, 2026 | |
| Andrew M. GreenSVP, Regulatory and Quality | Open market sell$38.8K | -2.8% | $26.02 | $38.8K | Sep 3, 2026 | Sep 4, 2026 | |
| Andrew M. GreenSVP, Regulatory and Quality | Open market sell$177K | -10.9% | $27.27 | $177K | Sep 2, 2026 | Sep 4, 2026 | |
| James P. MackinPresident & CEO | Open market sell$2.03M | -7.4% | $28.96 | $2.03M | Aug 19, 2026 | Aug 20, 2026 | |
| Andrew M. GreenSVP, Regulatory and Quality | Open market sell$17.6K | -1.0% | $28.55 | $17.6K | Aug 14, 2026 | Aug 17, 2026 | |
| Lance A. BerryEVP, COO, CFO & Treasurer | Open market sell$20.4K | -0.3% | $28.55 | $20.4K | Aug 14, 2026 | Aug 17, 2026 | |
| Jean F. HollowaySVP, General Counsel | Open market sell$27.8K | -0.5% | $28.49 | $27.8K | Aug 12, 2026 | Aug 12, 2026 | |
| Jean F. HollowaySVP, General Counsel | Open market sell$341K | -4.6% | $38.00 | $341K | Mar 4, 2026 | Mar 4, 2026 | |
| Amy HortonVP, Chief Accounting Officer | Open market sell$34K | -0.6% | $37.78 | $34K | Mar 3, 2026 | Mar 4, 2026 | |
| Jean F. HollowaySVP, General Counsel | Open market sell$145K | -1.9% | $37.78 | $145K | Mar 3, 2026 | Mar 4, 2026 | |
| Marshall S. StantonSVP, Clinical & MD Affair | Open market sell$81.2K | -3.5% | $37.78 | $81.2K | Mar 3, 2026 | Mar 4, 2026 | |
| John E. DavisChief Commercial Officer | Open market sell$173K | -1.9% | $37.78 | $173K | Mar 3, 2026 | Mar 4, 2026 | |
| Lance A. BerryEVP, COO, CFO & Treasurer | Open market sell$239K | -2.9% | $37.78 | $239K | Mar 3, 2026 | Mar 4, 2026 | |
| James P. MackinPresident & CEO | Open market sell$676K | -1.9% | $37.78 | $676K | Mar 3, 2026 | Mar 4, 2026 | |
| Amy HortonVP, Chief Accounting Officer | Open market sell$24.4K | -0.5% | $38.02 | $24.4K | Mar 2, 2026 | Mar 3, 2026 | |
| Marshall S. StantonSVP, Clinical & MD Affair | Open market sell$57.5K | -3.6% | $38.02 | $57.5K | Mar 2, 2026 | Mar 3, 2026 | |
| James P. MackinPresident & CEO | Open market sell$567K | -1.7% | $38.02 | $567K | Mar 2, 2026 | Mar 3, 2026 | |
| Jean F. HollowaySVP, General Counsel | Open market sell$83K | -1.3% | $38.02 | $83K | Mar 2, 2026 | Mar 3, 2026 | |
| Lance A. BerryEVP, COO, CFO & Treasurer | Open market sell$197K | -2.9% | $38.02 | $197K | Mar 2, 2026 | Mar 3, 2026 | |
| John E. DavisChief Commercial Officer | Open market sell$106K | -1.3% | $38.02 | $106K | Mar 2, 2026 | Mar 3, 2026 | |
| Amy HortonVP, Chief Accounting Officer | Open market sell$29.6K | -0.7% | $35.69 | $29.6K | Feb 24, 2026 | Feb 25, 2026 | |
| Marshall S. StantonSVP, Clinical & MD Affair | Open market sell$44.9K | -2.9% | $35.69 | $44.9K | Feb 24, 2026 | Feb 25, 2026 | |
| Jean F. HollowaySVP, General Counsel | Open market sell$59.5K | -1.1% | $35.69 | $59.5K | Feb 24, 2026 | Feb 25, 2026 | |
| James P. MackinPresident & CEO | Open market sell$497K | -1.8% | $35.69 | $497K | Feb 24, 2026 | Feb 25, 2026 | |
| Lance A. BerryEVP, COO, CFO & Treasurer | Open market sell$160K | -3.0% | $35.69 | $160K | Feb 24, 2026 | Feb 25, 2026 | |
| John E. DavisChief Commercial Officer | Open market sell$74.1K | -1.1% | $35.69 | $74.1K | Feb 24, 2026 | Feb 25, 2026 | |
| Amy HortonVP, Chief Accounting Officer | Open market sell$65.1K | -1.3% | $37.59 | $65.1K | Feb 23, 2026 | Feb 25, 2026 | |
| Marshall S. StantonSVP, Clinical & MD Affair | Open market sell$91.1K | -5.3% | $37.59 | $91.1K | Feb 23, 2026 | Feb 25, 2026 | |
| Jean F. HollowaySVP, General Counsel | Open market sell$116K | -2.0% | $37.59 | $116K | Feb 23, 2026 | Feb 25, 2026 | |
| James P. MackinPresident & CEO | Open market sell$788K | -2.6% | $37.59 | $788K | Feb 23, 2026 | Feb 25, 2026 | |
| Lance A. BerryEVP, COO, CFO & Treasurer | Open market sell$187K | -3.3% | $37.59 | $187K | Feb 23, 2026 | Feb 25, 2026 | |
| John E. DavisChief Commercial Officer | Open market sell$142K | -1.9% | $37.59 | $142K | Feb 23, 2026 | Feb 25, 2026 | |
| John E. DavisChief Commercial Officer | Open market sell$226K | -2.5% | $45.11 | $226K | Dec 15, 2025 | Dec 17, 2025 | |
| Amy HortonVP, Chief Accounting Officer | Open market sell$203K | -3.4% | $44.42 | $203K | Dec 8, 2025 | Dec 9, 2025 | |
| Jean F. HollowaySVP, General Counsel | Open market sell$239K | -3.3% | $45.30 | $239K | Dec 3, 2025 | Dec 4, 2025 | |
| Jean F. HollowaySVP, General Counsel | Open market sell$92.8K | -1.3% | $45.30 | $92.8K | Dec 3, 2025 | Dec 4, 2025 | |
| Elizabeth A. HoffDirector | Open market sell$189K | -13.4% | $45.10 | $189K | Nov 18, 2025 | Nov 19, 2025 | |
| Amy HortonVP, Chief Accounting Officer | Open market sell$274K | -4.2% | $45.73 | $274K | Nov 17, 2025 | Nov 18, 2025 | |
| Amy HortonVP, Chief Accounting Officer | Open market sell$160K | -2.4% | $45.86 | $160K | Nov 13, 2025 | Nov 14, 2025 | |
| John E. DavisChief Commercial Officer | Open market sell$301K | -3.2% | $45.86 | $301K | Nov 13, 2025 | Nov 14, 2025 | |
| James P. MackinPresident & CEO | Open market sell$1.57M | -4.1% | $45.86 | $1.57M | Nov 13, 2025 | Nov 14, 2025 | |
| Jean F. HollowaySVP, General Counsel | Open market sell$264K | -3.4% | $45.86 | $264K | Nov 13, 2025 | Nov 14, 2025 | |
| Marshall S. StantonSVP, Clinical & MD Affair | Open market sell$229K | -8.1% | $45.86 | $229K | Nov 13, 2025 | Nov 14, 2025 | |
| Jean F. HollowaySVP, General Counsel | Open market sell$132K | -1.7% | $44.62 | $132K | Nov 10, 2025 | Nov 12, 2025 | |
| James P. MackinPresident & CEO | Open market sell$784K | -2.1% | $44.62 | $784K | Nov 10, 2025 | Nov 12, 2025 | |
| John E. DavisChief Commercial Officer | Open market sell$151K | -1.6% | $44.62 | $151K | Nov 10, 2025 | Nov 12, 2025 | |
| Amy HortonVP, Chief Accounting Officer | Open market sell$79.8K | -1.2% | $44.62 | $79.8K | Nov 10, 2025 | Nov 12, 2025 | |
| Marshall S. StantonSVP, Clinical & MD Affair | Open market sell$114K | -4.0% | $44.62 | $114K | Nov 10, 2025 | Nov 12, 2025 |
End of history · 48 transactions